Effect of prostacyclin derivatives on platelet factor 3 availability.
Skopál
J
J
Chinoin Pharmaceutical and Chemical Works Ltd., Budapest, Hungary.
Kovács
M
M
Stadler
I
I
Galambos
G
G
Kovács
G
G
D000328:Adult; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors*; D001780:Blood Coagulation Tests; D003094:Collagen / Q000494:pharmacology; D004809:Ephedrine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011464:Epoprostenol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010977:Platelet Factor 3 / Q000037:antagonists & inhibitors* / Q000502:physiology
D001779:Blood Coagulation Factors; C053680:15-cyclopentyl-7-oxo-prostaglandin I2-ephedrine; C053676:7-oxo-prostaglandin I2-ephedrine; D010977:Platelet Factor 3; D003094:Collagen; D011464:Epoprostenol; D004809:Ephedrine